Business Context and Reporting Period
This Form 8-K Current Report was filed by InspireMD, Inc. (NSPR) on December 19, 2025, covering events occurring on December 17, 2025. The company is incorporated in Delaware and trades on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and officer compensation matters.
Material Changes
The primary material change reported is the resignation of Kathryn Arnold, a Class III member of the Board of Directors. Ms. Arnold served on the Compensation, Nominating and Corporate Governance, and Research and Development committees. Her resignation is effective December 31, 2025, and the company states it was not due to any disagreement regarding operations, policies, or practices.
Outlook, Risks, and Unusual Items
In connection with Ms. Arnold's resignation, the Compensation Committee approved a severance package valued at approximately $140,000. The package includes:
- Acceleration of unvested equity awards.
- Extension of stock option expiration dates by two years from the resignation effective date.
- Payment of three additional quarters of board and committee fees.
- A new grant of common stock and options (75% stock, 25% options) with an exercise price equal to the closing fair market value on December 30, 2025.
The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard disclosure regarding the director departure.
Investor Verification Checklist
- Verify the exact composition of the Board of Directors following the December 31, 2025 resignation.
- Confirm the impact of the $140,000 compensation package on the company's near-term cash flow and equity dilution.
- Review the company's subsequent filings for the appointment of a replacement director to fill the Class III vacancy.